Clifford Swan Investment Counsel Llc Buys Bristol-Myers Squibb Company, Stericycle, Teva Pharmaceutical Industries, Sells Gilead Sciences, Johnson Controls International PLC, The Hain Celestial Group

Pasadena, CA, based Investment company Clifford Swan Investment Counsel Llc buys Bristol-Myers Squibb Company, Stericycle, Teva Pharmaceutical Industries, Cerner, McKesson, SPDR S&P 500, iShares Intermediate Credit Bond, iPath Bloomberg Commodity Index Total Return ETN, Sprott Physical Silver Trust, Arthur J. Gallagher, sells Gilead Sciences, Johnson Controls International PLC, The Hain Celestial Group, Oaktree Capital Group LLC, BlackRock Capital Investment during the 3-months ended 2016-12-31, according to the most recent filings of the investment company, Clifford Swan Investment Counsel Llc. As of 2016-12-31, Clifford Swan Investment Counsel Llc owns 274 stocks with a total value of $1.5 billion. These are the details of the buys and sells.

For the details of CLIFFORD SWAN INVESTMENT COUNSEL LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=CLIFFORD+SWAN+INVESTMENT+COUNSEL+LLC

These are the top 5 holdings of CLIFFORD SWAN INVESTMENT COUNSEL LLC
  1. United Parcel Service Inc (UPS) - 449,253 shares, 3.47% of the total portfolio. Shares reduced by 2.83%
  2. Exxon Mobil Corp (XOM) - 509,631 shares, 3.09% of the total portfolio. Shares reduced by 0.95%
  3. Apple Inc (AAPL) - 358,623 shares, 2.79% of the total portfolio. Shares reduced by 1.51%
  4. Berkshire Hathaway Inc (BRK.B) - 248,635 shares, 2.73% of the total portfolio. Shares reduced by 1.31%
  5. Wells Fargo & Co (WFC) - 702,056 shares, 2.6% of the total portfolio. Shares reduced by 0.84%
New Purchase: McKesson Corp (MCK)

Clifford Swan Investment Counsel Llc initiated holdings in McKesson Corp. The purchase prices were between $124.11 and $165.82, with an estimated average price of $147.1. The stock is now traded at around $139.31. The impact to the portfolio due to this purchase was 0.05%. The holdings were 5,600 shares as of 2016-12-31.

New Purchase: iShares Intermediate Credit Bond (CIU)

Clifford Swan Investment Counsel Llc initiated holdings in iShares Intermediate Credit Bond. The purchase prices were between $107.47 and $111.1, with an estimated average price of $109.28. The stock is now traded at around $108.77. The impact to the portfolio due to this purchase was 0.02%. The holdings were 3,056 shares as of 2016-12-31.

New Purchase: iPath Bloomberg Commodity Index Total Return ETN (DJP)

Clifford Swan Investment Counsel Llc initiated holdings in iPath Bloomberg Commodity Index Total Return ETN. The purchase prices were between $22.56 and $24.36, with an estimated average price of $23.65. The stock is now traded at around $24.30. The impact to the portfolio due to this purchase was 0.02%. The holdings were 14,500 shares as of 2016-12-31.

New Purchase: Marriott International Inc (MAR)

Clifford Swan Investment Counsel Llc initiated holdings in Marriott International Inc. The purchase prices were between $66.61 and $86.05, with an estimated average price of $75.26. The stock is now traded at around $85.53. The impact to the portfolio due to this purchase was 0.01%. The holdings were 2,552 shares as of 2016-12-31.

New Purchase: Sprott Physical Silver Trust (PSLV)

Clifford Swan Investment Counsel Llc initiated holdings in Sprott Physical Silver Trust. The purchase prices were between $5.98 and $7.29, with an estimated average price of $6.56. The stock is now traded at around $6.74. The impact to the portfolio due to this purchase was 0.01%. The holdings were 15,250 shares as of 2016-12-31.

New Purchase: ishares Gold Trust (IAU)

Clifford Swan Investment Counsel Llc initiated holdings in ishares Gold Trust. The purchase prices were between $10.86 and $12.66, with an estimated average price of $11.71. The stock is now traded at around $11.86. The impact to the portfolio due to this purchase was 0.01%. The holdings were 17,860 shares as of 2016-12-31.

Added: Bristol-Myers Squibb Company (BMY)

Clifford Swan Investment Counsel Llc added to the holdings in Bristol-Myers Squibb Company by 71.72%. The purchase prices were between $49.23 and $59.61, with an estimated average price of $54.67. The stock is now traded at around $51.00. The impact to the portfolio due to this purchase was 0.37%. The holdings were 223,407 shares as of 2016-12-31.

Added: Stericycle Inc (SRCL)

Clifford Swan Investment Counsel Llc added to the holdings in Stericycle Inc by 36.90%. The purchase prices were between $71.61 and $80.09, with an estimated average price of $75.51. The stock is now traded at around $75.16. The impact to the portfolio due to this purchase was 0.15%. The holdings were 106,515 shares as of 2016-12-31.

Added: Teva Pharmaceutical Industries Ltd (TEVA)

Clifford Swan Investment Counsel Llc added to the holdings in Teva Pharmaceutical Industries Ltd by 104.04%. The purchase prices were between $35.03 and $45.68, with an estimated average price of $39.93. The stock is now traded at around $34.37. The impact to the portfolio due to this purchase was 0.14%. The holdings were 112,854 shares as of 2016-12-31.

Added: Cerner Corp (CERN)

Clifford Swan Investment Counsel Llc added to the holdings in Cerner Corp by 42.68%. The purchase prices were between $47.37 and $61.79, with an estimated average price of $53.08. The stock is now traded at around $53.71. The impact to the portfolio due to this purchase was 0.09%. The holdings were 90,732 shares as of 2016-12-31.

Added: SPDR S&P 500 (SPY)

Clifford Swan Investment Counsel Llc added to the holdings in SPDR S&P 500 by 23.65%. The purchase prices were between $208.55 and $227.76, with an estimated average price of $218.6. The stock is now traded at around $228.63. The impact to the portfolio due to this purchase was 0.04%. The holdings were 15,129 shares as of 2016-12-31.

Added: Arena Pharmaceuticals Inc (ARNA)

Clifford Swan Investment Counsel Llc added to the holdings in Arena Pharmaceuticals Inc by 21.16%. The purchase prices were between $1.35 and $1.86, with an estimated average price of $1.55. The stock is now traded at around $1.60. The impact to the portfolio due to this purchase was less than 0.01%. The holdings were 28,628 shares as of 2016-12-31.

Sold Out: Oaktree Capital Group LLC (OAK)

Clifford Swan Investment Counsel Llc sold out the holdings in Oaktree Capital Group LLC. The sale prices were between $37.35 and $42.7, with an estimated average price of $40.1.

Sold Out: BlackRock Capital Investment Corp (BKCC)

Clifford Swan Investment Counsel Llc sold out the holdings in BlackRock Capital Investment Corp. The sale prices were between $6.78 and $8.24, with an estimated average price of $7.51.

Sold Out: Conagra Brands Inc (CAG)

Clifford Swan Investment Counsel Llc sold out the holdings in Conagra Brands Inc. The sale prices were between $34.3 and $39.85, with an estimated average price of $37.37.

Sold Out: Visa Inc (V)

Clifford Swan Investment Counsel Llc sold out the holdings in Visa Inc. The sale prices were between $75.43 and $83.36, with an estimated average price of $80.4.

Sold Out: Exelon Corp (EXC)

Clifford Swan Investment Counsel Llc sold out the holdings in Exelon Corp. The sale prices were between $30 and $35.75, with an estimated average price of $33.24.

Sold Out: FirstEnergy Corp (FE)

Clifford Swan Investment Counsel Llc sold out the holdings in FirstEnergy Corp. The sale prices were between $30.06 and $34.5, with an estimated average price of $32.03.



Here is the complete portfolio of CLIFFORD SWAN INVESTMENT COUNSEL LLC. Also check out:

1. CLIFFORD SWAN INVESTMENT COUNSEL LLC's Undervalued Stocks
2. CLIFFORD SWAN INVESTMENT COUNSEL LLC's Top Growth Companies, and
3. CLIFFORD SWAN INVESTMENT COUNSEL LLC's High Yield stocks
4. Stocks that CLIFFORD SWAN INVESTMENT COUNSEL LLC keeps buying